117 results
Page 5 of 6
6-K
EX-99.2
g7kb0b1c904
19 May 20
Share Transfer Agreement
5:18pm
6-K
EX-99.2
gqlb78jcd43vx2f3r
22 Apr 20
Therapix Biosciences Announces Appointment of New CEO
5:30pm
424B4
fs3po25s
2 Apr 20
Prospectus supplement with pricing info
5:28pm
F-1/A
9h4fdz0
31 Mar 20
Registration statement (foreign) (amended)
11:31am
F-1/A
EX-4.7
j4opggrboq77xegk440
31 Mar 20
Registration statement (foreign) (amended)
11:31am
F-1/A
EX-4.7
h1pwyt
30 Mar 20
Registration statement (foreign) (amended)
12:29pm
F-1/A
r2i51h 24
30 Mar 20
Registration statement (foreign) (amended)
12:29pm
F-1/A
d2l094 b40m4so0bmpm
26 Mar 20
Registration statement (foreign) (amended)
12:00am
F-1/A
EX-1.1
vtnh rqcvexc03
26 Mar 20
Registration statement (foreign) (amended)
12:00am
F-1/A
EX-4.7
52ym1z2o
19 Mar 20
Registration statement (foreign) (amended)
12:21pm
F-1/A
vmsfwn82ge87jwjfzm0s
19 Mar 20
Registration statement (foreign) (amended)
12:21pm
F-1
3vt3q1g8ywz5d9 tc
31 Jan 20
Registration statement (foreign)
12:00am
6-K
EX-99.1
ppeor so6kfd
11 Dec 19
Annual and Special General Meeting of Shareholders
4:38pm
424B5
m9krd44uspx5g4s7d8f
5 Dec 19
Prospectus supplement for primary offering
5:29pm
6-K
EX-10.1
wqx3aeq a3bstzqx1y
4 Dec 19
Therapix Biosciences Announces Pricing of $1,250,000 Registered Direct Offering
9:26am
6-K
EX-99.1
zp850cdliu670
13 Nov 19
Therapix Biosciences Announces Positive Topline Results From Phase IIa Clinical Trial of THX-110 for Obstructive Sleep Apnea Program
4:07pm
6-K
EX-99.1
0ks7iy
7 Nov 19
Therapix Biosciences and Destiny Biosciences Global Corp. Mutually Decide to Discontinue Negotiations on Planned Merger
5:22pm
F-3/A
EX-4.2
w1fq 8cgx6l9
29 Aug 19
Shelf registration (foreign) (amended)
4:49pm
6-K
EX-99.1
zulw9z 8f1fo7d
31 Jul 19
Therapix Biosciences Announces Canadian Product LicenseĀ Issuance for TheraPEA (CannAmideā¢), a Non-Opiate Based Pain Management Supplement
4:03pm
6-K
EX-99.1
mpwh1zvs 4uc
23 Jul 19
Therapix Biosciences Signs LOI to Merge With Destiny Biosciences Global Corp. in a
4:05pm